ADMA Biologics: Differentiated Plasma Approach With Asymmetric Upside Potential (Upgrade)

Company Overview - ADMA Biologics, Inc. is a biologics company that specializes in producing immune globulin (IG) treatments, which are beneficial for treating immune deficiencies and infectious disease indications [1]. Market Position - The company is currently a small player in the large IG market and is anticipating expansion in its operations [1].